Biomedical Advanced Research And Development Authority Barda Broad Agency Announcement Baa

Work Detail

View Changes We Appreciate Your Interest In Partnering With Barda Due To The Covid 19 Response Any White Papers Or Full Proposals Submissions Other Than Those That Are In Support Of Covid 19 Will Be Put Into A Queue Once The Response To Covid 19 Has Subsided We Will Resume Normal Review Of Submissions For Other Research Areas Of Interests Barda Will Not Be Able To Meet The Timelines Highlighted In The Broad Agency Announcement Thank You For Understanding This Unprecedented Response And Delays That Will Occur The Latest Barda Broad Agency Announcement Baa Is Amendment 15 Posted On April 2 2020 Note Covid 19 Response Related Areas Of Interest Includes Aoi 7 7 1 Diagnostic Assay For Human Coronavirus Using Existing Fda Cleared Platforms Aoi 7 7 2 Point Of Care Diagnostic Assay For Detection Of Sars Cov 2 Virus Aoi 7 7 3 Diagnostic Assay For Detection Of Covid 19 Disease Sars Cov 2 Infection Aoi 8 3 Covid 19 Vaccine Aoi 9 2 Covid 19 Therapeutics Aoi 9 3 Immunomodulators Or Therapeutics Targeting Lung Repair Aoi 9 5 Pre Exposure And Post Exposure Prophylaxis Aoi 10 Respiratory Protective Devices Aoi 11 Ventilators Aoi 17 Advanced Manufacturing Technologies All Contracting Related Inquiries Should Be Sent To Barda Baa Hhs Gov Barda Will Conduct Rolling Reviews Of Covid 19 Response Related Full Proposals Only Barda Will Continuously Review And Expedite Covid 19 Response Related White Papers And Full Proposals Offeror Should Now Also Complete The Submission Data Integration Table The Final White Paper Submission Deadline Is October 31 2020 The Final Full Proposal Submission Deadline Is October 31 2020 Or As Specified In The Invitation Letter

Contact Information

Other Detail